Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
3.130
-0.040 (-1.26%)
At close: Sep 3, 2025, 4:00 PM
3.140
+0.010 (0.32%)
Pre-market: Sep 4, 2025, 8:41 AM EDT

SONN Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019 - 2020
214573535
Upgrade
Market Cap Growth
34.54%-13.25%-30.09%-79.64%0.50%-
Upgrade
Enterprise Value
211-222932
Upgrade
Last Close Price
3.136.6922.92258.721493.186332.48
Upgrade
PS Ratio
8.47233.5833.9320.5072.86-
Upgrade
PB Ratio
--8.96-22.19-2.831.5811.61
Upgrade
P/TBV Ratio
----1.5811.61
Upgrade
EV/Sales Ratio
21.1250.81-6.3560.68-
Upgrade
Debt / Equity Ratio
-0.02-0.27-0.90-0.100.010.12
Upgrade
Asset Turnover
0.260.010.030.020.03-
Upgrade
Quick Ratio
0.180.280.550.464.121.56
Upgrade
Current Ratio
0.260.660.860.664.301.62
Upgrade
Return on Equity (ROE)
----301.42%-197.66%-27822.18%
Upgrade
Return on Assets (ROA)
-223.80%-180.62%-208.63%-106.50%-84.78%-270.89%
Upgrade
Return on Capital (ROIC)
----184.48%-121.74%-2921.10%
Upgrade
Earnings Yield
-63.44%-170.95%-375.53%-414.34%-70.90%-69.20%
Upgrade
FCF Yield
-48.25%-197.85%-425.56%-387.18%-64.01%-44.75%
Upgrade
Buyback Yield / Dilution
-469.85%-404.96%-425.71%---
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q